DNA Testing for Epidermolytic Hyperkeratosis in Norfolk Terriers

The Norfolk Terrier is a cherished breed in the United States, known for its spirited nature and origins as a skilled working terrier. Originally bred to keep vermin in check, Norfolk Terriers have become lively family pets that bring energy and joy to American households. They thrive on plenty of exercise and mental engagement, which makes them particularly good companions for families with children.

Typically living 12-15 years, Norfolk Terriers are generally healthy dogs. Still, like other purebred dogs, they may inherit certain genetic conditions. One key concern among breeders and owners is epidermolytic hyperkeratosis (EHK), a hereditary skin disorder impacting this breed. Although DNA testing isn't mandatory in the U.S., many responsible Norfolk Terrier breeders choose to perform health screenings to help produce healthier litters and offer puppy buyers peace of mind, especially given the typical price range of $1,500 or more for a registered puppy.

Understanding Epidermolytic Hyperkeratosis in Norfolk Terriers

Epidermolytic hyperkeratosis, occasionally called ichthyosis, is a chronic inherited skin disease that specifically affects Norfolk Terriers. It causes the skin to become fragile and sensitive, prone to blistering and peeling. Over time, affected dogs develop thickened, scaly patches that may crack and cause discomfort. Dogs with EHK can also show hyperpigmentation — darker patches of skin — and toughened footpads, which can hinder their movement and overall well-being.

Genetic Inheritance of Epidermolytic Hyperkeratosis

The disease follows an autosomal recessive inheritance pattern, which means a Norfolk Terrier must inherit two copies of the mutated gene (one from each parent) to display symptoms. Dogs with just one copy are carriers and usually show no signs of the condition.

Dogs' genetic status regarding epidermolytic hyperkeratosis can be broken down as:

• Clear: No mutated gene copies; they neither develop nor transmit the disease.
• Carrier: One copy of the mutation; healthy but able to pass the gene to their offspring.
• Affected: Two copies of the mutation; dogs display clinical symptoms of EHK.

Knowing the genetic status of breeding dogs enables better planning to prevent affected puppies:

• Breeding two clear dogs will result in only clear puppies.
• Two affected parents will produce only affected offspring.
• Breeding two carriers carries a 25% chance for affected puppies, 50% to be carriers, and 25% clear puppies.
• A pairing of clear and affected dogs yields all carrier puppies.
• Breeding a clear dog with a carrier results in half the puppies clear and half carriers.
• A carrier bred to an affected dog produces half affected and half carriers.

Steps to DNA Test Your Norfolk Terrier for Epidermolytic Hyperkeratosis

If you're planning to breed your Norfolk Terrier or want to know its genetic health, DNA testing is a crucial step to determine the risk of passing on EHK. In the U.S., several accredited genetic testing companies offer this service, such as Paw Print Genetics and the Orthopedic Foundation for Animals.

Step 1: Choose a reputable genetic testing lab

Ensure the lab you select offers testing specifically for epidermolytic hyperkeratosis in Norfolk Terriers and confirm their sample collection guidelines.

Step 2: Order a DNA test kit

These kits usually contain materials for collecting a cheek swab or blood sample. Some providers allow you to collect the sample at home, while others may require a visit to your veterinarian.

Step 3: Collect the DNA sample carefully

Follow all instructions to take a clean swab from your dog's cheek or have your veterinarian draw a blood sample. Accurate sample collection is vital for reliable results.

Step 4: Mail the sample to the laboratory

Use the provided prepaid envelope or the courier method specified by the lab to send the sample securely.

Step 5: Await your results

Results are typically returned within 10-15 business days, showing whether your dog is clear, a carrier, or affected by EHK.

Step 6: Make responsible use of the results

Share the findings with your veterinarian and, if you are a breeder, consider submitting the information to relevant American breeding clubs or registries. Use these results to make informed breeding and care decisions to promote the breed's health.

The Importance of DNA Testing for Ethical Breeding

Without genetic screening, breeding can unintentionally increase the number of puppies affected by epidermolytic hyperkeratosis. Testing helps breeders identify carriers and affected dogs, allowing them to avoid mating combinations that produce affected pups. This practice helps preserve the breed's health for the future.

Responsible breeders in the U.S. often find Norfolk Terrier puppies from parents with known genetic health, reassuring buyers that their new pets are less likely to face hereditary health problems and are appropriate family companions.

Care and Management of Dogs with Epidermolytic Hyperkeratosis

Currently, there is no cure for EHK, but affected dogs can have a good quality of life with proper management. Treatment typically involves gentle, medicated shampoos to soothe skin irritation, moisturizing ointments to keep the skin flexible, and close observation to prevent secondary infections. Regular check-ups with your veterinarian are critical to monitor the condition and adjust care as needed.

Summary

Epidermolytic hyperkeratosis is a serious inherited skin disease that Norfolk Terrier breeders and owners in the U.S. should understand well. Genetic testing through DNA analysis is a valuable resource currently accessible across American veterinary genetic labs. Incorporating genetic screening into breeding practices reduces the occurrence of EHK and fosters healthier generations of this lively breed.

For those looking to bring a Norfolk Terrier into their family, asking breeders about the genetic testing history and choosing puppies from health-screened parents remains a responsible way to ensure a happy, healthy pet companion.